BG102716A - Метод за лекуване на сърдечна недостатъчност със средства противодействащи на ендотелина - Google Patents

Метод за лекуване на сърдечна недостатъчност със средства противодействащи на ендотелина

Info

Publication number
BG102716A
BG102716A BG102716A BG10271698A BG102716A BG 102716 A BG102716 A BG 102716A BG 102716 A BG102716 A BG 102716A BG 10271698 A BG10271698 A BG 10271698A BG 102716 A BG102716 A BG 102716A
Authority
BG
Bulgaria
Prior art keywords
treatment
endotheline
formulations
opposing
cardiac insufficiency
Prior art date
Application number
BG102716A
Other languages
English (en)
Inventor
Joseph Lynch
You-Tang Shen
Original Assignee
Joseph Lynch
You-Tang Shen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joseph Lynch, You-Tang Shen filed Critical Joseph Lynch
Publication of BG102716A publication Critical patent/BG102716A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)

Abstract

Изобретението се използва за предотвратяване и/или лечение на сърдечна недостатъчност. То се отнасядо съединения, които се противопоставят на ендотелина.
BG102716A 1996-04-04 1998-08-21 Метод за лекуване на сърдечна недостатъчност със средства противодействащи на ендотелина BG102716A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1488296P 1996-04-04 1996-04-04
PCT/US1997/003737 WO1997037665A1 (en) 1996-04-04 1997-03-19 Method of treating heart failure with endothelin antagonists

Publications (1)

Publication Number Publication Date
BG102716A true BG102716A (bg) 1999-09-30

Family

ID=21768326

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102716A BG102716A (bg) 1996-04-04 1998-08-21 Метод за лекуване на сърдечна недостатъчност със средства противодействащи на ендотелина

Country Status (25)

Country Link
US (3) US5834483A (bg)
EP (1) EP0906108B1 (bg)
JP (2) JP3345891B2 (bg)
KR (1) KR20000005178A (bg)
CN (1) CN1215335A (bg)
AT (1) ATE297739T1 (bg)
AU (1) AU723351B2 (bg)
BG (1) BG102716A (bg)
BR (1) BR9708525A (bg)
CA (1) CA2249330C (bg)
CZ (1) CZ296098A3 (bg)
DE (1) DE69733557T2 (bg)
EA (1) EA003587B1 (bg)
EE (1) EE9800315A (bg)
ES (1) ES2241047T3 (bg)
HU (1) HUP9903893A3 (bg)
IL (1) IL126175A (bg)
IS (1) IS4847A (bg)
NO (1) NO984564L (bg)
NZ (1) NZ331789A (bg)
PL (1) PL329077A1 (bg)
SK (1) SK130098A3 (bg)
TR (1) TR199801988T2 (bg)
UA (1) UA50761C2 (bg)
WO (1) WO1997037665A1 (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA50761C2 (uk) 1996-04-04 2002-11-15 Банью Фармасьютікал Ко., Лтд. Спосіб запобігання та/або лікування серцевих захворювань, фармацевтична композиція та спосіб запобігання та/або лікування серцевої недостатності та дисфункції шлуночків в організмі теплокровної тварини
WO1998006700A1 (en) * 1996-08-09 1998-02-19 Merck & Co., Inc. Stereoselective deoxygenation reaction
WO1999037639A1 (en) 1998-01-21 1999-07-29 Banyu Pharmaceutical Co., Ltd. Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
EP1577310A1 (en) * 2002-12-27 2005-09-21 Kaneka Corporation Processes for producing optically active 2-thiomethyl-3-phenylpropionic acid derivative and for producing intermediate therefor
MXPA06005518A (es) 2003-11-17 2006-08-17 Novartis Ag Uso de inhibidores de la dipeptidil peptidasa iv.
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
TW200605867A (en) 2004-03-17 2006-02-16 Novartis Ag Use of organic compounds
JP4967136B2 (ja) 2005-06-24 2012-07-04 国立大学法人 東京医科歯科大学 薬剤溶出性ステント
TW201136582A (en) 2010-03-16 2011-11-01 Novartis Ag Improved pharmaceutical compositions of aliskiren and methods of delivery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971959A (en) * 1987-04-14 1990-11-20 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
GB9007762D0 (en) * 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
US5565485A (en) * 1993-03-19 1996-10-15 Merck & Co., Inc. Biphenyl compounds useful or endothelin antagonists
US5571813A (en) * 1993-06-10 1996-11-05 Beiersdorf-Lilly Gmbh Fused pyrimidine compounds and their use as pharmaceuticals
CN1049219C (zh) * 1993-08-18 2000-02-09 万有制药株式会社 具有内皮素拮抗活性的芳香杂环并环戊烯衍生物
US5389620A (en) * 1993-08-18 1995-02-14 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
US5658943A (en) * 1995-01-05 1997-08-19 Warner-Lambert Company Phenylalanine derivatives as endothelin antagonists
UA50761C2 (uk) * 1996-04-04 2002-11-15 Банью Фармасьютікал Ко., Лтд. Спосіб запобігання та/або лікування серцевих захворювань, фармацевтична композиція та спосіб запобігання та/або лікування серцевої недостатності та дисфункції шлуночків в організмі теплокровної тварини

Also Published As

Publication number Publication date
PL329077A1 (en) 1999-03-15
CN1215335A (zh) 1999-04-28
NO984564L (no) 1998-12-04
EA003587B1 (ru) 2003-06-26
EP0906108A4 (en) 2000-12-06
AU2202597A (en) 1997-10-29
ES2241047T3 (es) 2005-10-16
JP2000510824A (ja) 2000-08-22
CA2249330C (en) 2005-08-09
AU723351B2 (en) 2000-08-24
NO984564D0 (no) 1998-09-30
UA50761C2 (uk) 2002-11-15
JP2002220337A (ja) 2002-08-09
CZ296098A3 (cs) 1999-06-16
JP3345891B2 (ja) 2002-11-18
US6087360A (en) 2000-07-11
HUP9903893A3 (en) 2001-05-28
IS4847A (is) 1998-09-15
WO1997037665A1 (en) 1997-10-16
EP0906108B1 (en) 2005-06-15
HUP9903893A2 (hu) 2001-04-28
CA2249330A1 (en) 1997-10-16
ATE297739T1 (de) 2005-07-15
KR20000005178A (ko) 2000-01-25
TR199801988T2 (xx) 2000-08-21
US6380195B1 (en) 2002-04-30
NZ331789A (en) 2000-05-26
DE69733557D1 (de) 2005-07-21
BR9708525A (pt) 1999-08-03
IL126175A (en) 2003-05-29
EP0906108A1 (en) 1999-04-07
SK130098A3 (en) 1999-05-07
IL126175A0 (en) 1999-05-09
DE69733557T2 (de) 2005-11-03
US5834483A (en) 1998-11-10
EA199800889A1 (ru) 1999-04-29
EE9800315A (et) 1999-06-15

Similar Documents

Publication Publication Date Title
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
MY117032A (en) A novel compound form.
IL121170A0 (en) Compositions for the treatment of dermatological disorders
EP0626174A3 (en) Method and composition for the prophylaxis and / or treatment of underactive organs.
PL328858A1 (en) Immunogenous peptides
IL110943A0 (en) Compositions for the treatment of skin disorders
EP0961613A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF BONE RESORPTION DISORDERS, INCLUDING OSTEOPOROSIS
ZA943744B (en) Therapeutic substituted guanidines
AU2160492A (en) Treatment of human diseases involving dysregulation or dysfunction of the nervous system
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
BG102818A (bg) D-манитол и метод за неговото получаване
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
BG102716A (bg) Метод за лекуване на сърдечна недостатъчност със средства противодействащи на ендотелина
ZA977310B (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
IL104940A0 (en) Method and composition for the treatment of osteoporosis
MX9703944A (es) Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis.
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
IN167848B (bg)
BG102667A (bg) Състав, съдържащ диосгенин
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
GR76280B (bg)
GB9510162D0 (en) Compositions for the treatment of skin conditions
ZA949564B (en) Method for treating constipation using dimeticone.